Andreas Ritzén
- Organic Chemistry top 5%
- Molecular Biology
- Oncology top 10%
- Pharmacology top 10%
- Cell Biology top 10%
- Co-authors
- Kenji NamotoK. C. NicolaouTrond UlvenTorbjörn FrejdParaskevi GiannakakouC. ThomsenJesper Mosolff MathiesenTrine P. Petersen
- Topics
- Chemical Synthesis and Analysis (8 papers)Cancer Treatment and Pharmacology (7 papers)Asymmetric Hydrogenation and Catalysis (4 papers)
- Journals
- Journal of the American Chemical SocietyAngewandte Chemie International EditionChemical Communications
- Partner nations
- DenmarkUnited StatesSweden
In The Last Decade
Andreas Ritzén
29 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 79
- Organic Chemistry 530
- Molecular Biology 472
- Oncology 282
- Pharmacology 154
- Cell Biology 137
Countries citing papers authored by Andreas Ritzén
This map shows the geographic impact of Andreas Ritzén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Ritzén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Ritzén more than expected).
Fields of papers citing papers by Andreas Ritzén
This network shows the impact of papers produced by Andreas Ritzén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Ritzén. The network helps show where Andreas Ritzén may publish in the future.
Co-authorship network of co-authors of Andreas Ritzén
This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Ritzén. A scholar is included among the top collaborators of Andreas Ritzén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Ritzén. Andreas Ritzén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 19 | |
| 2 | 41 | |
| 3 | 19 | |
| 4 | 4-Phenyl imidazoles: A novel class of phosphodiesterase 10A (PDE10A) inhibitors as a potential new generation of antipsychotics | 1 |
| 5 | 41 | |
| 6 | 46 | |
| 7 | 22 | |
| 8 | 19 | |
| 9 | 39 | |
| 10 | 88 | |
| 11 | 102 | |
| 12 | 31 | |
| 13 | 34 | |
| 14 | 9 | |
| 15 | 44 | |
| 16 | 23 | |
| 17 | 96 | |
| 18 | 17 | |
| 19 | 19 | |
| 20 | 26 |
About Andreas Ritzén
Andreas Ritzén is a scholar working on Organic Chemistry, Oncology and Toxicology, having authored 29 papers that have together received 1.0k indexed citations. Recurring topics across this work include Chemical Synthesis and Analysis (8 papers), Cancer Treatment and Pharmacology (7 papers) and Asymmetric Hydrogenation and Catalysis (4 papers). The work is most often cited by research in Organic Chemistry (530 citations), Oncology (282 citations) and Pharmacology (154 citations). Andreas Ritzén has collaborated with scholars based in Denmark, United States and Sweden. Frequent co-authors include Kenji Namoto, K. C. Nicolaou, Trond Ulven, Torbjörn Frejd, Paraskevi Giannakakou, C. Thomsen, Jesper Mosolff Mathiesen, Trine P. Petersen, K. C. Nicolaou and Pradip K. Sasmal. Their work appears in journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Chemical Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.